GNMK News and Press, GenMark Diagnostics Inc. From 08/05/20

The poor control of COVID-19 in the United States has created an unprecedented testing opportunity for GenMark ( GNMK ), and so far the company is doing a good job of leveraging that opportunity to get hardware in the field and establish relationships with healthcare facilities that may well...

Vapotherm (NYSE: VAPO )   -26%  on Q2 earnings . More news on: Vapotherm, Inc., New Relic, Inc., Alterity Therapeutics Limited, Stocks on the move, , Read more ...

Image source: The Motley Fool. GenMark Diagnostics Inc   (NASDAQ: GNMK) Q2 2020 Earnings Call Aug 4, 2020 , 4:30 p.m. ET Scott Mendel -- President and Chief Executive Officer Continue reading

GenMark Diagnostics, Inc. (GNMK) Q2 2020 Earnings Conference Call August 04, 2020 04:30 PM ET Company Participants Scott Mendel - President & Chief Executive Officer Johnny Ek - Chief Financial Officer Conference Call Participants Max Masucci - Canaccord Genuity Ryan Bl...

CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended June 30, 2020. Second Quarter 2020 Highlights T...

Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...

CARLSBAD, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Tuesday, August 4, 2020. Management will hold a conference call to review the company's financ...

By Michael Cintolo , Cabot Heritage Corporation GenMark ( GNMK ) is a testing company. Its proprietary eSensor detection technology (dubbed eSensor XT-8) and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations, and s...

National General Holdings (NASDAQ: NGHC ) +66%  on being acquired by Allstate. More news on: National General Holdings Corp., NanoViricides, Inc., Intersect ENT, Inc., Stocks on the move, , Read more ...

GenMark Diagnostics (NASDAQ: GNMK ) expects Q2 sales to be ~$40.1M, up 118% Y/Y, as COVID-19 impacted second quarter placements and revenue. More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...